What is the Return on Assets (ROA) of Soligenix this year?
The Return on Assets (ROA) of Soligenix is -0.63 undefined this year.
Soligenix ROA 2024
Soligenix ROA
-0.63
Ticker
SNGX
ISIN
US8342233074
WKN
A2AS7Q
In 2024, Soligenix's return on assets (ROA) was -0.63, a -35.14% increase from the -0.97 ROA in the previous year.
Soligenix Aktienanalyse
What does Soligenix do?
Soligenix Inc. is a biopharmaceutical company specialized in the development of treatment and prevention methods for serious diseases. It was founded in 1987 and is headquartered in Princeton, New Jersey. The business model of Soligenix Inc. is based on the research and development of innovative therapies for diseases that are currently difficult to treat or have no known cure. The company's research and development focus on three core areas: vaccines, cancer therapies, and rare diseases. In the field of vaccines, Soligenix Inc. has focused on developing therapies against biological threats such as anthrax, smallpox, or botulinum toxin-like toxins. These threats are not only a potential danger to national security but can also occur in the form of natural disasters or terrorist attacks. Soligenix Inc. has several promising vaccine candidates in clinical trials, including an anthrax vaccine that works faster and safer than currently available vaccines. In the field of cancer therapy, the company focuses on developing new immunotherapies for the treatment of solid tumors. Soligenix Inc. uses a technology platform called "RiVax" based on the inactivation of botulinum toxin. This platform has already proven promising in redirecting the body's immune system to tumor cells and killing them. As the last core area, the company is dedicated to the treatment of rare diseases that are often overlooked and insufficiently treated. Soligenix Inc. has already developed a promising candidate for the treatment of oropharyngeal candidiasis (fungal infections in the mouth and throat) and is in phase III clinical trials. Overall, Soligenix Inc. has developed a range of promising products in various stages of clinical trials. In addition to the mentioned candidates, the company has also developed a promising treatment for relieving the side effects of cancer chemotherapy. This product called SGX942 is currently in phase III clinical trials. In addition to ongoing clinical studies, Soligenix Inc. has also established strong partnerships with government organizations such as the US National Institutes of Health or the Biomedical Advanced Research and Development Authority (BARDA). These partnerships are important to secure funding for ongoing research projects and allow the company to bring its products to market quickly. Soligenix Inc. has experienced strong growth in recent years and has established itself as a key player in the biopharmaceutical industry. The company has received several awards for its research work and innovation potential in the past and seems to be on a good path to bring further groundbreaking therapies to the market. Soligenix ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Soligenix's Return on Assets (ROA)
Soligenix's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Soligenix's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Soligenix's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Soligenix’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Soligenix stock
What was the ROA of Soligenix compared to the previous year?
The ROA of Soligenix has increased by -35.14% compared to the previous year.
What consequences do high ROA have for investors of Soligenix?
A high ROA is advantageous for investors of Soligenix, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Soligenix?
A low ROA can be unfavorable for investors of Soligenix as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Soligenix affect the company?
An increase in ROA of Soligenix can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Soligenix impact the company?
A reduction in the ROA of Soligenix can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Soligenix?
Some factors that can influence the ROA of Soligenix include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Soligenix important for investors?
The ROA of Soligenix is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Soligenix take to improve ROA?
To improve ROA, Soligenix can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Soligenix pay?
Over the past 12 months, Soligenix paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Soligenix is expected to pay a dividend of 0 USD.
What is the dividend yield of Soligenix?
The current dividend yield of Soligenix is .
When does Soligenix pay dividends?
Soligenix pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Soligenix?
Soligenix paid dividends every year for the past 0 years.
What is the dividend of Soligenix?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Soligenix located?
Soligenix is assigned to the 'Health' sector.
Wann musste ich die Aktien von Soligenix kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Soligenix from 11/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/9/2024.
When did Soligenix pay the last dividend?
The last dividend was paid out on 11/9/2024.
What was the dividend of Soligenix in the year 2023?
In the year 2023, Soligenix distributed 0 USD as dividends.
In which currency does Soligenix pay out the dividend?
The dividends of Soligenix are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Soligenix stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Soligenix
Our stock analysis for Soligenix Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Soligenix Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
